Latest Mass Tort News and Updates

Researchers from Cedars-Sinai Medical Center in Los Angeles published a study in the American Journal of Gastroenterology, last week, indicating that the use of a class of medications known as proton pump inhibitors (PPI), which includes…

Food and Drug Administration's (FDA) ongoing study over Essure indicates that more than 20% of women implanted with the birth control device may be suffering from allergic or…

On Tuesday, Judge Ronald E. Wilson of the First Judicial Circuit in West Virginia, who oversees the state’s asbestos docket, issued a notice announcing that the jury selection in…

In a motion, dated 23rd of July, for preliminary approval of the class action settlement, BASF Catalysts LLC and its longtime national counsel agreed to establish a $72.5 million settlement fund to compensate those plaintiffs, who alleged…

A new study by researchers of the Emory School of Medicine on the interstitial cystitis drug, Elmiron, indicates that vision problems can continue to progress even after the usage of…

On September 23, two plaintiffs who claim that the bladder medication, Elmiron, results in permanent vision problems have asked the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate and…

JAMA Psychiatry published a study earlier this month, indicating that children who were prescribed selective serotonin reuptake inhibitor (…

On Monday, California's third virtual Asbestos trial kicked off with an argument by a former Navy sailor's counsel that the plaintiff was exposed to cancer-causing asbestos,…

U.S. District Judge William H. Orrick III, overseeing the federal JUUL multidistrict litigation (MDL), issued an order establishing the method for…

On Friday, Indivior PLC, a Chesterfield County-based drug company, agreed to pay $600 million after its subsidiary Indivior Solutions Inc., pleaded guilty in federal court in Abingdon over its…